(CP) - Cholesterol may not just be bad for your heart.
A study suggests problems with cholesterol regulation in the insulin-producing cells of the pancreas may be responsible for the development of Type 2 (formerly known as late onset) diabetes.
The work, by scientists at Vancouver's Child and Family Research Institute, was done in mice. And the researchers would have to show that the same mechanism is seen in people.
COLUMBIA, Mo., Feb. 7 A University of Missouri-Columbia study says as little as 15 minutes a day of acute exercise can help prevent and fight diabetes.
NEW YORK, Jan. 31 (Xinhua) -- One in eight adults in New York City have diabetes, and nearly twice as many appear to be developing it, the New York Times reported on Wednesday.
What's one of the most important rules in medicine? Never take a drug if a natural and safer remedy provides the same relief. Yet millions of people take cholesterol-lowering drugs to prevent heart attacks.
“It's something you constantly have to be diligent with,” said Pat Costello, a diabetic referring to her blood sugar levels.
A new study comparing three major diabetes drugs -- Avandia, Glucophage (metformin), and Micronase (glyburide) -- shows that all three drugs have pros and cons to consider.
Sanofi has reported positive results for Acomplia for type II diabetes. Acomplia has been tested for weight loss, but this is the first study in which the drug was tested by itself as a treatment of type II diabetes. Patients receiving Acomplia 20 mg per day for six months significantly lowered their HbA1c levels.
Type 1 diabetes is a growing health problem among European children. European data indicate that the disease incidence has increased five- to six-fold among children under the age of 15 years after World War II, and there are no signs that the increase in incidence is levelling off.
High blood sugar is among the world's top five killers, a Harvard study shows.